Literature DB >> 14550281

Aberrant methylation of the specific CpG island portion regulates cyclooxygenase-2 gene expression in human gastric carcinomas.

Keun Hur1, Sang Hyun Song, Hye Seung Lee, Woo Ho Kim, Yung-Jue Bang, Han-Kwang Yang.   

Abstract

Although it has been well established that overexpression of cyclooxygenase-2 (Cox-2) favors tumorigenesis and metastasis, the molecular mechanism that regulates Cox-2 expression has not been well defined in gastric carcinoma. Aberrant methylation of the CpG island is known to be one of the powerful mechanisms for the suppression of gene expression, and usually, CpG islands are very rich in promoter region and exon-1 region. But, it is controversial whether Cox-2 gene expression is regulated by methylation of promoter region or exon-1 region. In this study, we examined whether the hyper-methylation mediated transcriptional silencing of Cox-2 also occurred in human gastric carcinoma tissues and which portion of CpG island methylation is important in Cox-2 gene expression. Genomic DNAs from human gastric carcinoma tissues were treated with three methylation-sensitive restriction enzymes and then Southern blot analysis was performed. Out of 30 primary gastric tumor samples, 26 cases (86.6%) showed overexpression of Cox-2. Four cases (13.3%) with relatively decreased Cox-2 gene expression were associated with the presence of aberrant methylation of Cox-2 CpG island. We also found that methylation of promoter region and not exon-1 region is related with the transcriptional silencing of Cox-2 in gastric carcinoma cancer by detailed methylation mapping using bisulfite sequencing analysis. Our results suggest that the DNA methylation-mediated transcriptional silencing of Cox-2 is a predominant mechanism for the down-regulation of Cox-2 expression in human gastric carcinoma. Furthermore, the results suggest that methylation of not exon-1 region but promoter region is important to regulation of Cox-2 gene expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14550281     DOI: 10.1016/j.bbrc.2003.09.095

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Promoter Gene Methylation Regulates Clooxygenase-2 Expression in Androgen-Dependent and Independent Prostate Cancer Cells.

Authors:  Chung-Yi Liu; Shih-Huan Su; Tzu-Hsuan Chang; Ming-Li Hsieh; Ying-Hsu Chang; Jacob See-Tong Pang; Cheng-Keng Chuang
Journal:  World J Oncol       Date:  2022-06-22

2.  COX-2 expression is upregulated by DNA hypomethylation after hematopoietic stem cell transplantation.

Authors:  Racquel Domingo-Gonzalez; Steven K Huang; Yasmina Laouar; Carol A Wilke; Bethany B Moore
Journal:  J Immunol       Date:  2012-09-24       Impact factor: 5.422

3.  COX-2 gene expression in colon cancer tissue related to regulating factors and promoter methylation status.

Authors:  Annika Gustafsson Asting; Helena Carén; Marianne Andersson; Christina Lönnroth; Kristina Lagerstedt; Kent Lundholm
Journal:  BMC Cancer       Date:  2011-06-13       Impact factor: 4.430

4.  Cyclooxygenase-2-Mediated Up-Regulation of Mitochondrial Transcription Factor A Mitigates the Radio-Sensitivity of Cancer Cells.

Authors:  Fan Tang; Rui Zhang; Jun Wang
Journal:  Int J Mol Sci       Date:  2019-03-11       Impact factor: 5.923

5.  Increased adiposity, inflammation, metabolic disruption and dyslipidemia in adult male offspring of DOSS treated C57BL/6 dams.

Authors:  Alexis M Temkin; Robert R Bowers; Candice Z Ulmer; Kayla Penta; John A Bowden; Jennifer Nyland; John E Baatz; Demetri D Spyropoulos
Journal:  Sci Rep       Date:  2019-02-06       Impact factor: 4.379

6.  Evaluation of epigenetic modulation of cyclooxygenase-2 as a prognostic marker for hepatocellular carcinoma.

Authors:  A Fernández-Alvarez; C Llorente-Izquierdo; R Mayoral; N Agra; L Boscá; M Casado; P Martín-Sanz
Journal:  Oncogenesis       Date:  2012-07-09       Impact factor: 7.485

7.  Methylation status of COX-2 in blood leukocyte DNA and risk of gastric cancer in a high-risk Chinese population.

Authors:  Hui-juan Su; Yang Zhang; Lian Zhang; Jun-ling Ma; Ji-You Li; Kai-feng Pan; Wei-cheng You
Journal:  BMC Cancer       Date:  2015-12-16       Impact factor: 4.430

8.  Allelic variation in the canine Cox-2 promoter causes hypermethylation of the canine Cox-2 promoter in clinical cases of renal dysplasia.

Authors:  Mary H Whiteley
Journal:  Clin Epigenetics       Date:  2014-04-03       Impact factor: 6.551

9.  Epigenetic regulation of cyclooxygenase-2 by methylation of c8orf4 in pulmonary fibrosis.

Authors:  Iona C Evans; Josephine L Barnes; Ian M Garner; David R Pearce; Toby M Maher; Xu Shiwen; Elisabetta A Renzoni; Athol U Wells; Christopher P Denton; Geoffrey J Laurent; David J Abraham; Robin J McAnulty
Journal:  Clin Sci (Lond)       Date:  2016-01-07       Impact factor: 6.124

10.  Mechanisms by Which 17β-Estradiol (E2) Suppress Neuronal cox-2 Gene Expression.

Authors:  Winfred Stacey; Shreyas Bhave; Rosalie M Uht
Journal:  PLoS One       Date:  2016-09-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.